Zobrazeno 1 - 10
of 601
pro vyhledávání: ''
Publikováno v:
Annals of Internal Medicine; 8/1/2017, Vol. 167 Issue 3, p192-199, 11p, 3 Diagrams, 3 Charts
Publikováno v:
Annals of Internal Medicine. 174:431-432
Autor:
William G. Kussmaul
Publikováno v:
Annals of Internal Medicine
Mackey and colleagues reported a systematic review that found high-certainty evidence that angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with greater illness severity in patients with COVID-19. The edit
Autor:
Vineet Punia
Publikováno v:
Annals of Internal Medicine. 173:771-772
Autor:
Michael Tanner
Publikováno v:
Annals of Internal Medicine. 174:JC41
SOURCE CITATION Yusuf S, Joseph P, Dans A, et al. Polypill with or without aspirin in persons without cardiovascular disease. N Engl J Med. 2021;384:216-28. 33186492.
Publikováno v:
Annals of Internal Medicine. 174:431
TO THE EDITOR: Brailovski and colleagues (1) attributed their patient's rosuvastatin-induced myotoxicity to a possible rosuvastatin–canagliflozin interaction. The assumed interaction was based on known and speculated factors. The known factors incl
Autor:
Chou, Roger, Huffman, Laurie Hoyt
Publikováno v:
Annals of Internal Medicine; 10/2/2007, Vol. 147 Issue 7, p505-W155, 24p, 12 Charts
Publikováno v:
Annals of Internal Medicine. 173:71-72
Autor:
Michael Tanner
Publikováno v:
Annals of Internal Medicine. 173:JC52
SOURCE CITATION Mantsiou C, Karagiannis T, Kakotrichi P, et al. Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes
Publikováno v:
Annals of Internal Medicine. 173:771